The data that emerged indicate that alterations of the RAS/MAPK signaling pathway and the SHP2 protein are related to an increase in osteoclastic activity and, therefore, bone resorption, which over time could explain the tendency towards osteopenia/osteoporosis in these subjects. The gene discussed is PTPN11; the disease is Osteopenia.